Principal Financial Group’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.98M Buy
1,409,242
+9,800
+0.7% +$47.7K ﹤0.01% 1503
2025
Q4
$6.54M Buy
1,399,442
+8,230
+0.6% +$37.3K ﹤0.01% 1516
2025
Q3
$6.62M Sell
1,391,212
-8,953
-0.6% -$30.8K ﹤0.01% 1484
2025
Q2
$4.34M Buy
1,400,165
+15,152
+1% +$45.2K ﹤0.01% 1624
2025
Q1
$4.6M Sell
1,385,013
-43,331
-3% -$152K ﹤0.01% 1595
2024
Q4
$4.46M Sell
1,428,344
-26,798
-2% -$91.2K ﹤0.01% 1625
2024
Q3
$5.29M Buy
1,455,142
+86,764
+6% +$353K ﹤0.01% 1555
2024
Q2
$6.27M Buy
1,368,378
+361,201
+36% +$1.76M ﹤0.01% 1483
2024
Q1
$4.97M Buy
1,007,177
+11,677
+1% +$56.4K ﹤0.01% 1570
2023
Q4
$4.69M Buy
995,500
+24,837
+3% +$92.9K ﹤0.01% 1577
2023
Q3
$2.48M Sell
970,663
-16,413
-2% -$52K ﹤0.01% 1725
2023
Q2
$4.42M Sell
987,076
-439,378
-31% -$1.99M ﹤0.01% 1581
2023
Q1
$7.09M Buy
1,426,454
+29,950
+2% +$97K 0.01% 1408
2022
Q4
$2.88M Sell
1,396,504
-67,588
-5% -$152K ﹤0.01% 1699
2022
Q3
$3.85M Buy
1,464,092
+377,744
+35% +$1.32M ﹤0.01% 1579
2022
Q2
$3.93M Buy
1,086,348
+209,160
+24% +$1.06M ﹤0.01% 1633
2022
Q1
$6.78M Sell
877,188
-4,207
-0.5% -$47.3K ﹤0.01% 1543
2021
Q4
$12.4M Buy
881,395
+58,930
+7% +$869K 0.01% 1271
2021
Q3
$14.4M Buy
+822,465
New +$14.5M 0.01% 1186

Other funds holding SOPH

Principal Financial Group's SOPH Position: Q1 2026 in Review

Principal Financial Group increased its SOPHiA GENETICS (SOPH) stake by 0.7% in Q1 2026, buying an estimated $47.7K and bringing the position to 1,409,242 shares worth $6.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Principal Financial Group first reported a position in SOPH in Q3 2021 and has held it in 19 quarters since. The position peaked at $14.4M in Q3 2021. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Principal Financial Group held 1,409,242 shares of SOPHiA GENETICS worth $6.98M as of Q1 2026.
  • Principal Financial Group bought 9,800 SOPHiA GENETICS shares in Q1 2026, an estimated $47.7K.
  • SOPHiA GENETICS made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #1503 holding.
  • Principal Financial Group first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 19 quarters since.
  • Principal Financial Group's SOPHiA GENETICS position peaked at $14.4M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.